Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NYSE MKT LLC:ONVO)

4.33
Delayed Data
As of Jul 27
 +0.13 / +3.10%
Today’s Change
1.60
Today|||52-Week Range
4.35
+73.90%
Year-to-Date
No recent news for Organovo Holdings Inc.

Today’s Trading

Previous close4.20
Today’s open4.19
Day’s range4.16 - 4.35
Volume1,400,952
Average volume (3 months)794,007
Market cap$388.0M
Dividend yield--
Data as of 07/27/2016

Growth & Valuation

Earnings growth (last year)-13.16%
Earnings growth (this year)+1.16%
Earnings growth (next 5 years)--
Revenue growth (last year)+159.72%
P/E ratioNM
Price/Sales131.78
Price/Book6.24

Competitors

 Today’s
change
Today’s
% change
VYGRVoyager Therapeutics...-0.03-0.21%
NDRMNeuroderm Ltd+0.39+2.23%
AGENAgenus Inc0.000.00%
CGENCompugen Ltd+0.15+2.27%
Data as of 07/27/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.5M
Annual profit (last year)-$38.6M
Net profit margin-2,601.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Keith Murphy
Chief Scientific Officer
Sharon Collins Presnell
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs